Table 3.
PDNVs as drug carrier
| Source of the nanovectors/nanocarriers | Target | Drug substances | Ref. |
|---|---|---|---|
| Grapefruit | Colon cancer | Doxorubicin (Dox), curcumin | [111] |
| Tumor cells (4T1, GL26, A549, CT26, or SW620) | JSI-124 (anti-Stat3 inhibitor), paclitaxel (PTX), luciferase gene siRNA | [32] | |
| GL26 brain tumor cells | miR17 | [114] | |
| Intestinal macrophages | Methotrexate (MTX) | [53] | |
| Liver Kupffer cells | miR-18a | [112] | |
| Broccoli | Colon tissue | Sulforaphane | [64] |
| Apple | Human epithelial colorectal adenocarcinoma (Caco-2) cells | miRNAs | [67] |
| Citrus limon | Chronic myeloid leukemia (CML) | Proteins | [55] |
| Ginger | Colon cancer cell lines | Doxorubicin (Dox) | [40] |
| Colon-26 cells and HT-29 cells | |||
| RAW 264.7 macrophages and Colon-26 cells | siRNA-CD98 | [113] | |
| Intestinal epithelial cells (IEC) | miRNA, 6-gingerol, and 6-shogaol | [44] | |